Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 4,048,000 | 3,831,000 | 4,191,000 | 3,736,000 | 4,443,000 |
| Cost of Goods | 1,108,000 | 1,063,000 | 1,075,000 | 987,000 | 1,245,000 |
| Gross Profit | 2,940,000 | 2,768,000 | 3,116,000 | 2,749,000 | 3,198,000 |
| Operating Expenses | 2,410,000 | 2,094,000 | 2,603,000 | 2,178,000 | 2,139,000 |
| Operating Income | 530,000 | 674,000 | 513,000 | 571,000 | 1,059,000 |
| Other Income | 0 | 0 | 0 | -1,830,000 | 0 |
| Pre-tax Income | 530,000 | 674,000 | 513,000 | -1,259,000 | 1,059,000 |
| Income Tax | 0 | 51,000 | -411,000 | -546,000 | 251,000 |
| Net Income Continuous | 530,000 | 623,000 | 924,000 | -713,000 | 808,000 |
| Minority Interests | -6,000 | 14,000 | -1,000 | -2,000 | 163,000 |
| Net Income | $536,000 | $609,000 | $925,000 | $-711,000 | $645,000 |
| EPS Basic Total Ops | 0.33 | 0.37 | 0.57 | -0.43 | 0.38 |
| EPS Basic Continuous Ops | 0.32 | 0.38 | 0.57 | -0.43 | 0.48 |
| EPS Diluted Total Ops | 0.32 | 0.37 | 0.57 | -0.43 | 0.38 |
| EPS Diluted Continuous Ops | 0.32 | 0.38 | 0.57 | -0.43 | 0.48 |
| EBITDA(a) | $719,000 | $887,000 | $1,004,000 | $766,000 | $1,207,000 |